Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01921751
Title High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Radiation Therapy Oncology Group
Indications

pancreatic adenocarcinoma

Therapies

Gemcitabine + Nab-paclitaxel

Capecitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.